Abu Eid, RashaWard, Frank James2022-09-222022-09-222021-12Abu Eid, R & Ward, F J 2021, 'Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients  ', Immunology Letters, vol. 240, pp. 1-8. https://doi.org/10.1016/j.imlet.2021.09.0050165-2478https://hdl.handle.net/2164/19216Funding This work was supported by Friends of ANCHOR pilot research award [grant number RS 2019 004, 2020-2021]8652868engCOVID-19PI3KAktmTORImmune modulationThrombosisRK DentistryOtherRS 2019 0042020-2021RKTargeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients  Journal item10.1016/j.imlet.2021.09.005240